-
Why Are Entasis Therapeutics Shares Moving Higher On Thursday?
Thursday, September 16, 2021 - 2:28pm | 171Read More...Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) stock is up sharply after the journal Nature published an article on the potential of its preclinical candidate ETX0462, which could become the first of a new class of antibiotics. ETX0462 is under development for multidrug-resistant...
-
Paratek's Antibiotic Gets FDA Orphan Drug Tag For Lung Infection
Thursday, August 19, 2021 - 6:36am | 333Read More...The FDA has granted Orphan Drug Designation to Paratek Pharmaceuticals Inc's (NASDAQ: PRTK), Nuzyra (omadacycline) for infections caused by Nontuberculous Mycobacteria (NTM). The orphan drug designation includes NTM pulmonary disease caused by Mycobacterium...
-
Hoth Therapeutics Inks Research Pact For Critical Studies Of HT-006 Antibiotic
Wednesday, March 17, 2021 - 2:20pm | 205Read More...Hoth Therapeutics Inc (NASDAQ: HOTH) has entered into a Research Agreement with the University of Cincinnati Research Institute to perform critical antimicrobial characterization studies with HT-006 as part of the streamlined drug development plan. HT-006 is under development...
-
Environmental-Minded McDonald's Shareholder Sees Proposals Shot Down At Company's Annual Meeting
Wednesday, May 31, 2017 - 5:08pm | 472Read More...McDonald’s Corporation (NYSE: MCD) shareholders have voted down proposals to update the company’s policies regarding the use of antibiotics in its meat, to assess the environmental impact of polystyrene foam cups and to release a report on the company’s charitable contributions....
